Risk Stratification of Cardiovascular Disease according to Age Groups in New Prevention Guidelines: A Review
Journal of Lipid and Atherosclerosis · 2023 · 12 (2) · 96
DOI: 10.12997/jla.2023.12.2.96 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Lipid and Atherosclerosis, 2023. Verfasst von Kwang-Il Kim. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Age is a strong risk factor for cardiovascular disease. Accordingly, most cardiovascular risk prediction models have included age as an independent risk factor. There is much evidence that effective management of cardiovascular risk factors improves clinical outcomes even in older adults. However, there are concerns that intensive treatment for older adults increases the risk of adverse events. For hypertensive patients, intensive blood pressure reduction with combination therapy increases the risk of syncope, acute kidney injury, and falls. Intensive glucose-lowering therapy among older patients with diabetes increases the risk of hypoglycemia or cognitive impairment. These findings suggest that a balanced approach for older adults is required to increase the benefits and decrease the risk of side effects. In contrast to older people, the estimated 10-year cardiovascular risk in young and healthy individuals is low. However, the lifetime cardiovascular risk in these patients is actually high. The 2021 European Society of Cardiology guideline on cardiovascular disease prevention in clinical practice has been published. It proposed a different risk stratification and recommendation for treatment according to age group, based on the concept of avoiding undertreatment in young people and overtreatment in older persons. Although the guideline recommends age-dependent risk stratification, risk categories should not be applied to the mandatory initiation of drug treatment. In all age groups, other factors such as lifetime cardiovascular risk, treatment benefit and harm, comorbidities, frailty, and patient preferences should be considered when managing patients for primary prevention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Kwang-Il Kim
Zitieren
APA
Kim, K. I. (2023). Risk Stratification of Cardiovascular Disease according to Age Groups in New Prevention Guidelines: A Review. Journal of Lipid and Atherosclerosis, 12(2), 96. https://doi.org/10.12997/jla.2023.12.2.96
Vancouver
Kim KI. Risk Stratification of Cardiovascular Disease according to Age Groups in New Prevention Guidelines: A Review. Journal of Lipid and Atherosclerosis. 2023;12(2):96. doi:10.12997/jla.2023.12.2.96
BibTeX
@article{Kim2023,
author = {Kim, Kwang-Il},
title = {Risk Stratification of Cardiovascular Disease according to Age Groups in New Prevention Guidelines: A Review},
journal = {Journal of Lipid and Atherosclerosis},
year = {2023},
volume = {12},
number = {2},
pages = {96},
doi = {10.12997/jla.2023.12.2.96}
}
EUVIMED